{"id":"984","presentation":"997 - Evaluation of Prophylactic Valganciclovir for Cytomegalovirus (CMV) in Pediatric Heart Transplant Recipients","session":"PO-2-PEDS - Poster Session 2: Pediatric Transplantation","filename":"tp_32X48_ISHLT Poster Heart Rev3.pdf","speaker":"G. Nance<small>, Atlanta, GA, United States of America<\/small>","photo":"","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-presentations\/ishlt2018\/984\/jpg\/tp_32x48_ishltposterheartrev3\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E5947\/session_token\/7298cce702ff15f645095861abfc932e","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]